ICICI Securities: India’s Aggregate R&D Spend By Listed Companies Remains Low At Rs 360 Billion In FY20
A technician holds an agar plate containing bacteria cell culture at a Bugworks Research India Ltd. laboratory in Bengaluru, India. (Photographer: Samyukta Lakshmi/Bloomberg)  

ICICI Securities: India’s Aggregate R&D Spend By Listed Companies Remains Low At Rs 360 Billion In FY20

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportun...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.